Xeris Biopharma Holdings Inc

XERS NASDAQ Healthcare & Biotech United States US98422E1038
10.50 $
3.24 %

Xeris Biopharma Holdings Inc specializes in the development and commercialization of innovative injectable therapies for endocrine diseases and urgent care needs.